Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 158

1.

Bone mineral density in patients with longstanding type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.

Alhuzaim ON, Lewis EJH, Lovblom LE, Cardinez M, Scarr D, Boulet G, Weisman A, Lovshin JA, Lytvyn Y, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZI, Perkins BA.

J Diabetes Complications. 2018 Dec 22. pii: S1056-8727(18)31081-X. doi: 10.1016/j.jdiacomp.2018.12.009. [Epub ahead of print]

PMID:
31003922
2.

Molecular regulation of the renin-angiotensin system by sodium-glucose cotransporter 2 inhibition in type 1 diabetes mellitus.

Kopecky C, Lytvyn Y, Domenig O, Antlanger M, Kovarik JJ, Kaltenecker CC, Poglitsch M, Perkins BA, Rye KA, Cherney DZI, Säemann MD.

Diabetologia. 2019 Apr 11. doi: 10.1007/s00125-019-4871-8. [Epub ahead of print] No abstract available.

PMID:
30976852
3.

Uric Acid Levels Correlate with Sensory Nerve Function in Healthy Subjects.

Abraham A, Katzberg HD, Lovblom LE, Perkins BA, Bril V.

Can J Neurol Sci. 2019 Mar 18:1-5. doi: 10.1017/cjn.2019.9. [Epub ahead of print]

PMID:
30880660
4.

Risk Factors for Kidney Disease in Type 1 Diabetes.

Perkins BA, Bebu I, de Boer IH, Molitch M, Tamborlane W, Lorenzi G, Herman W, White NH, Pop-Busui R, Paterson AD, Orchard T, Cowie C, Lachin JM; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.

Diabetes Care. 2019 May;42(5):883-890. doi: 10.2337/dc18-2062. Epub 2019 Mar 4.

PMID:
30833370
5.

Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.

Lytvyn Y, Bjornstad P, Lovshin JA, Boulet G, Farooqi MA, Lai V, Tse J, Cham L, Lovblom LE, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Advani A, Sochett E, Perkins BA, Cherney DZI.

Am J Kidney Dis. 2019 Feb 22. pii: S0272-6386(19)30044-7. doi: 10.1053/j.ajkd.2018.12.034. [Epub ahead of print]

PMID:
30799029
6.

Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.

Lytvyn Y, Bjornstad P, Lovshin JA, Singh SK, Boulet G, Farooqi MA, Lai V, Tse J, Cham L, Lovblom LE, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Advani A, Sochett E, Perkins BA, Cherney DZI.

Diabetes Obes Metab. 2019 Feb 13. doi: 10.1111/dom.13665. [Epub ahead of print]

PMID:
30761725
7.

Association between allopurinol and cardiovascular outcomes and all-cause mortality in diabetes: A retrospective, population-based cohort study.

Weisman A, Tomlinson GA, Lipscombe LL, Perkins BA, Hawker GA.

Diabetes Obes Metab. 2019 Feb 8. doi: 10.1111/dom.13656. [Epub ahead of print]

PMID:
30734980
8.

Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Lovshin JA, Lytvyn Y, Lovblom LE, Katz A, Boulet G, Bjornstad P, Lai V, Cham L, Tse J, Orszag A, Keenan HA, Paul N, Bril V, Wong DT, McReelis KD, Brent MH, Perkins BA, Cherney DZI.

Diabetes Care. 2019 Feb;42(2):273-280. doi: 10.2337/dc18-1809. Epub 2018 Dec 6.

PMID:
30523033
9.

The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.

Bjornstad P, Singh SK, Snell-Bergeon JK, Lovshin JA, Lytvyn Y, Lovblom LE, Rewers MJ, Boulet G, Lai V, Tse J, Cham L, Orszag A, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

Diabetes Obes Metab. 2019 Mar;21(3):575-583. doi: 10.1111/dom.13556. Epub 2018 Nov 11.

PMID:
30311395
10.

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.

Rosenstock J, Marquard J, Laffel LM, Neubacher D, Kaspers S, Cherney DZ, Zinman B, Skyler JS, George J, Soleymanlou N, Perkins BA.

Diabetes Care. 2018 Dec;41(12):2560-2569. doi: 10.2337/dc18-1749. Epub 2018 Oct 4.

PMID:
30287422
11.

Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Lovshin JA, Bjornstad P, Lovblom LE, Bai JW, Lytvyn Y, Boulet G, Farooqi MA, Santiago S, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

Diabetes Care. 2018 Dec;41(12):2570-2578. doi: 10.2337/dc18-1236. Epub 2018 Oct 1.

PMID:
30275283
12.

Sex differences in neuropathic pain in longstanding diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.

Cardinez N, Lovblom LE, Bai JW, Lewis E, Abraham A, Scarr D, Lovshin JA, Lytvyn Y, Boulet G, Farooqi MA, Orszag A, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZ, Perkins BA.

J Diabetes Complications. 2018 Jul;32(7):660-664. doi: 10.1016/j.jdiacomp.2018.05.001. Epub 2018 May 5.

PMID:
29929836
13.

Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study.

Perkins BA, Lovblom LE, Bril V, Scarr D, Ostrovski I, Orszag A, Edwards K, Pritchard N, Russell A, Dehghani C, Pacaud D, Romanchuk K, Mah JK, Jeziorska M, Marshall A, Shtein RM, Pop-Busui R, Lentz SI, Boulton AJM, Tavakoli M, Efron N, Malik RA.

Diabetologia. 2018 Aug;61(8):1856-1861. doi: 10.1007/s00125-018-4653-8. Epub 2018 Jun 4.

14.

Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.

Scarr D, Lovblom LE, Cardinez N, Orszag A, Farooqi MA, Boulet G, Weisman A, Lovshin JA, Ngo M, Paul N, Keenan HA, Brent MH, Cherney DZ, Bril V, Perkins BA.

PLoS One. 2018 Apr 30;13(4):e0196647. doi: 10.1371/journal.pone.0196647. eCollection 2018.

15.

Neuropathy.

Diabetes Canada Clinical Practice Guidelines Expert Committee, Bril V, Breiner A, Perkins BA, Zochodne D.

Can J Diabetes. 2018 Apr;42 Suppl 1:S217-S221. doi: 10.1016/j.jcjd.2017.10.028. No abstract available.

PMID:
29650100
16.

Sex differences in neuropathic pain intensity in diabetes.

Abraham A, Barnett C, Katzberg HD, Lovblom LE, Perkins BA, Bril V.

J Neurol Sci. 2018 May 15;388:103-106. doi: 10.1016/j.jns.2018.03.008. Epub 2018 Mar 6.

PMID:
29627001
17.

Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Bjornstad P, Lovshin JA, Lytvyn Y, Boulet G, Lovblom LE, Alhuzaim ON, Farooqi MA, Lai V, Tse J, Cham L, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

Diabetes Care. 2018 Apr;41(4):831-839. doi: 10.2337/dc17-2475. Epub 2018 Feb 2.

18.

Laboratory Abnormalities in Polyneuropathy and Electrophysiological Correlations.

Abraham A, Breiner A, Barnett C, Katzberg HD, Ngo M, Lovblom LE, Perkins BA, Bril V.

Can J Neurol Sci. 2018 May;45(3):346-349. doi: 10.1017/cjn.2017.298. Epub 2018 Feb 13.

PMID:
29433597
19.

Nerve function varies with hemoglobin A1c in controls and type 2 diabetes.

Abraham A, Barnett C, Katzberg HD, Lovblom LE, Perkins BA, Bril V.

J Diabetes Complications. 2018 Apr;32(4):424-428. doi: 10.1016/j.jdiacomp.2017.12.007. Epub 2017 Dec 21.

PMID:
29422233
20.

Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.

Lovshin JA, Boulet G, Lytvyn Y, Lovblom LE, Bjornstad P, Farooqi MA, Lai V, Cham L, Tse J, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZ.

JCI Insight. 2018 Jan 11;3(1). pii: 96968. doi: 10.1172/jci.insight.96968. eCollection 2018 Jan 11.

Supplemental Content

Loading ...
Support Center